Oesophageal varices: Assessment of the risk of bleeding and mortality

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 8, 2000, Pages 842-848

  Fevery, J ^a   Nevens, F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Doppler sonography; Hepatic venous pressure gradient; Portal hypertension; Variceal bleeding; Variceal pressure; blocker

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE 5 NITRATE; NADOLOL; PROPRANOLOL; SPIRONOLACTONE;

AZYGOS VEIN; DIAGNOSTIC PROCEDURE; DOPPLER ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGOSCOPY; ESOPHAGUS PRESSURE; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER VEIN; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VEIN BLOOD FLOW; VENOUS PRESSURE;

EID: 0033803929     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02211.x     Document Type: Review

References (87)

1. The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices
2. Prophylactic sclerotherapy for esophageal varices: Long-term results of a single-centre trial
3. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis
4. The course of patients after variceal hemorrhage
5. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis
6. Pathophysiology of portal hypertension and its complications
7. The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide
8. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats
9. Aspects of natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisolone
10. Incidence of large esophageal varices in patients with cirrhosis. Application to prophylaxis of first bleeding
11. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices
12. The natural history of varices
13. Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic patients
14. Prevention of variceal rebleeding
15. Hepatic venous pressure measurement: An old test as a new prognostic marker in cirrhosis?
16. Portal pressure: Presence of gastroesophageal varices and variceal bleeding
17. Prognostic indicators in alcoholic cirrhotic men
18. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices
19. Effects of Vasopressin on portal pressure during hemorrhage from esophageal varices
20. Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis
21. Haemodynamic assessement
22. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis
23. Prediction of variceal hemorrhage by esophageal endoscopy
24. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study
25. Prediction of variceal hemorrhage in cirrhosis: A prospective follow-up study
26. Measurement of azygos venous blood flow by a continuous thermal dilution technique: An index of blood flow through gastroesophageal collaterals in cirrhosis
27. Hemodynamic evaluation of the patient with portal hypertension
28. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis: Lack of correlation with esophageal varices and gastrointestinal bleeding: Effect of propranolol
29. Predictive value of ultrasonography in the screening of non-ascitic cirrhotic patients with large varices
30. Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding?
31. Prevalence of spontaneous hepatofugal flow in liver cirrhosis. Clinical and endoscopical correlation in 228 patients
32. Timing of the first variceal hemorrhage in cirrhotic patients: Prospective evaluation of Doppler flowmetry, endoscopy and clinical parameters
33. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: Relationships with portal hemodynamics
34. Splenic Doppler impedance indices: Influence of different portal hemodynamic conditions
35. Inter-observer and inter-equipment variability of echo-Doppler examination in the portal vein: Effect of a cooperative training program
36. Variability of splanchnic blood flow measurements using MR velocity mapping under fasting post-prandial conditions - Comparison with echo-Doppler
37. Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices with Doppler sonography: Comparison between acute and chronic effects
38. The relationship of endoscopy, portal Doppler ultrasound flowmetry, and clinical and biochemical tests in cirrhosis
39. 'Congestion index' of the portal vein
40. Hemodynamics of the left gastric vein in portal hypertension
41. Hemodynamic factors involved in the development and rupture of esophageal varices: A pathophysiologic approach to treatment
42. Intravascular oesophageal variceal pressure assessed by endoscopic fine needle puncture under basal conditions, Valsalva's manoeuvre and after glyceryltrinitrate application
43. Pressure of intraoesophageal varices assessed by fine needle puncture: Its relation to endoscopic signs and severity of liver disease in patients with cirrhosis
44. The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis
45. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: Comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy
46. Endoscopic measurement of variceal pressure in cirrhosis: Correlation with portal pressure and variceal hemorrhage
47. Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension
48. Assessment of variceal pressure by continuous non-invasive endoscopic registration: A placebo controlled evaluation of the effect of terlipressin and octreotide
49. Measurement of variceal pressure with an endoscopic pressure sensitive gauge: Validation and effect of propranolol therapy in chronic conditions
50. Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension
51. Comparison of high-resolution endoluminal sonography to video endoscopy in the detection and evaluation of esophageal varices
52. Portal blood flow: Measurement with MR imaging
53. Azygous blood flow: Phase contrast quantitation in volunteers and patients with portal hypertension pre- and postintrahepatic shunt placement
54. Volumetric flow rates in the portal venous system: Measurement with cine phase-contrast MR imaging
55. The treatment of portal hypertension: A meta-analytic review
56. Agreement among multiple observers on endoscopic diagnosis of oesophageal varices before bleeding
57. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study
58. Survival and prognostic indicators in compensated and decompensated cirrhosis
59. Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding
60. Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score
61. Prediction of outcome following acute variceal hemorrhage
62. Prognostic significance of serum bile acids in cirrhosis
63. The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death
64. Systemic antibiotic prophylaxis after gastroin-testinal hemorrhage in cirrhotic patients with a high risk of infection
65. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage
66. The prognosis of idiopathic portal hypertension in Japan
67. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial
68. A predictive model for failure to control bleeding during acute variceal haemorrhage
69. Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: A multicenter study
70. Survival in alcoholic liver cirrhosis: Prognostic value of portal pressure, size of esophageal varices and biochemical data. Comparison with Child Classification
71. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage
72. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis
73. Survival in hepatitis-B cirrhosis compared to alcoholic cirrhosis in patients with Child's C liver disease: A prospective study of endoscopic sclerotherapy for bleeding oesophageal varices
74. Portal hypertension and hepatic blood flow. Review: Pharmacotherapeutic agents in the treatment of portal hypertension
75. Prevention of first bleeding in cirrhosis: A meta-analysis of randomized trials of nonsurgical treatment
76. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials
77. Prophylaxis of first variceal bleeding
78. Primary prophylaxis of variceal bleeding in cirrhosis: A cost-effectiveness analysis
79. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension
80. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis
81. The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites
82. Effects of varying doses of spironolactone without and with nitrates on portal vein pressure and kidney function in partial portal vein ligated rats
83. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
84. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis
85. The response of variceal pressure to pharmacotherapy is a predictor of the risk of variceal bleeding in cirrhotic patients
86. The effect of propranolol on variceal pressure is not different between patients with cirrhosis and patients with non-cirrhotic portal hypertension